Deep Dive Audio
FDA Fast-Tracks New Obesity Drug Foundayo in Record 50 Days
The FDA has approved Foundayo (orforglipron), a new weight management drug, in just 50 days under an expedited review program. Indicated for adults with obesity or overweight plus weight-related health conditions, the drug showed statistically significant weight reduction in two 72-week clinical trials. This marks the only metabolic health drug approval in the past two weeks, arriving nearly 10 months ahead of its original review deadline.
Deep Dive Audio
0:00--:--